Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report  
Real-time Quote. Real-time Tradegate - 07/17 03:59:22 pm
25.55 EUR   -0.12%
07/16EVOTEC : expands its iPSC discovery platform
AQ
07/15EVOTEC : Expands its ipsc discovery platform
EQ
07/12EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/11/2019 07/12/2019 07/15/2019 07/16/2019 07/17/2019 Date
25.04(c) 25.07(c) 25.76(c) 25.58(c) 25.58 Last
955 489 535 898 1 045 411 653 168 404 675 Volume
-1.22% +0.12% +2.75% -0.70% 0.00% Change
More quotes
Financials (EUR)
Sales 2019 417 M
EBIT 2019 76,6 M
Net income 2019 55,3 M
Finance 2019 64,1 M
Yield 2019 -
Sales 2020 462 M
EBIT 2020 81,2 M
Net income 2020 52,6 M
Finance 2020 83,5 M
Yield 2020 -
P/E ratio 2019 64,0x
P/E ratio 2020 64,3x
EV / Sales2019 9,03x
EV / Sales2020 8,11x
Capitalization 3 828 M
More Financials
Company
Evotec specializes in research and development services for the pharmaceutical and biotechnological industries. The group's activity is organized around 3 areas: - development of broadband screening systems; - research and development of pharmaceutical products: for the neurologic, oncologic,... 
More about the company
Surperformance© ratings of Evotec SE
Trading Rating : Investor Rating :
More Ratings
Latest news on EVOTEC SE
07/16EVOTEC : expands its iPSC discovery platform
AQ
07/15EVOTEC : Expands its ipsc discovery platform
EQ
07/12EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
07/08Eurofins to slow pace of M&A, expand in emerging markets
RE
07/08EVOTEC : and venture capital consortium form 'Breakpoint Therapeutics GmbH'
AQ
07/08EVOTEC : And venture capital consortium form 'breakpoint therapeutics gmbh'
EQ
07/04EVOTEC : completes acquisition of Just Biotherapeutics
AQ
07/03EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
07/03EVOTEC : Completes acquisition of just biotherapeutics
EQ
06/28EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
More news
Analyst Recommendations on EVOTEC SE
More recommendations
Stock Trading Strategies
EVOTEC AG - 05/10
Good timing to go long again
BUY
More Stock Trading Analysis
Sector news : Biotechnology & Medical Research - NEC
09:10aGILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
07/16GSK's two-drug HIV Dovato treatment meets main goal in study
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
More sector news : Biotechnology & Medical Research - NEC
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 26,20  €
Last Close Price 25,53  €
Spread / Highest target 29,3%
Spread / Average Target 2,62%
Spread / Lowest Target -21,7%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE47.31%4 217
IQVIA HOLDINGS INC34.78%31 409
LONZA GROUP32.31%25 111
CELLTRION, INC.--.--%20 827
INCYTE CORPORATION25.62%17 419
EXACT SCIENCES CORPORATION82.17%15 001